Kailera Therapeutics Inc is a clinical-stage biotechnology company. Kailera Therapeutics (NAS: KLRA) is based in Waltham, MA and was founded in 2024. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). It has raised $1.6 billion.
Last price · $/share
—
Implied valuation
$1.5B
Total raised
$1.6B
Last round
—
No prints on record
No secondary trades in Kailera Therapeutics (NAS: KLRA) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Where Kailera Therapeutics (NAS: KLRA) prices come from
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Kailera Therapeutics (NAS: KLRA) stock.
